Nebenwirkungen · Prevenar 13
Prevenar 13 suspension for injection in multidose container pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) · Abschnitt 4.8 · PDF-Seite 57
HOS-121948 · Präparat HOS-095437
Adverse reactions reported in clinical studies or from the postmarketing experience for all age groups are listed in this section per system organ class, in decreasing order of frequency and seriousness. The frequency is defined as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-02-05T10:20:00Z · SHA-256 6a86f7a7aa34133091bc2ef414feeace046fcc5a28168dfdcb5f7fd2514bcdce · Passage ffb1dd37ba99447601b297e8c7e626980f7ffd3ceeebb9f75ddf20c7b856b370 · Zeichen 251–683 im Abschnitt